Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$18.97 - $23.71 $1.21 Million - $1.52 Million
-64,000 Reduced 17.96%
292,400 $5.73 Million
Q4 2023

Feb 12, 2024

SELL
$20.42 - $24.22 $1.59 Million - $1.89 Million
-78,000 Reduced 17.96%
356,400 $8.21 Million
Q3 2023

Nov 09, 2023

BUY
$21.63 - $27.92 $713,790 - $921,360
33,000 Added 8.22%
434,400 $9.99 Million
Q2 2023

Aug 07, 2023

BUY
$24.01 - $29.93 $7.31 Million - $9.11 Million
304,400 Added 313.81%
401,400 $10.5 Million
Q1 2023

May 04, 2023

BUY
$21.0 - $28.71 $420,000 - $574,200
20,000 Added 25.97%
97,000 $2.68 Million
Q4 2022

May 23, 2023

SELL
$22.29 - $35.91 $445,800 - $718,199
-20,000 Reduced 20.62%
77,000 $1.75 Million
Q4 2022

Feb 13, 2023

BUY
$22.29 - $35.91 $1.72 Million - $2.77 Million
77,000 New
77,000 $1.75 Million

Others Institutions Holding PRVA

About Privia Health Group, Inc.


  • Ticker PRVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 111,326,000
  • Market Cap $2.28B
  • Description
  • Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population...
More about PRVA
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.